We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Allow Generic Drugmakers to Make Label Changes Independent of Innovators
FDA to Allow Generic Drugmakers to Make Label Changes Independent of Innovators
July 8, 2013
The FDA intends to publish a proposed rule allowing generic drugmakers to make changes to product labels independent of a brand-name manufacturer.